Navigation Links
Rad-5v signal extraction pulse oximeter™

ProductsRad-5v signal extraction pulse oximeter™
Company Masimo Corporation
Item Rad-5v signal extraction pulse oximeter™
Features 
  • Masimo SET V4.3
  • Lightweight
  • Designed for spot check monitoring
  • 72 hours of trending memory
  • SmartTone
  • Protective boot cover with built in tabletop stand (optional)
Description Rad-5v signal extraction pulse oximeter™
Info Masimo Corporation
Customer Service: (800) 326-4890
Web site: http://www.masimo.com

Related medicine products :

1. Rad-5 signal extraction pulse oximeter™
2. Simpulse® VariCare™ System
3. Simpulse® PLUS System
4. Impulse II
5. Impulse
6. Ecopulse Pulsed Irrigation System
7. Simpulse Solo Pulsed Lavage System
8. Simpulse VariCare System
9. Simpulse PLUS System
10. Impulse 3002 Imaging Table (With 2 Speed, Multi-directional Top Slide)
Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Softgoods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and In
...gned for the treatment of diaphyseal fractures of ...s post operative support following intra medullary...ion. The brace allows for movement of joints above...ty and encouraging bone growth. For a more custom ...
The UltraLite Post Op Brace provides a fixed or range of motion control. The UltraLite Post Op Brace indications include: , Post knee trauma , Peri-operative use , Conservative management of isolated
Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Softgoods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and In
Medicine Products:
(Date:12/2/2008)... death risk, data review finds , , TUESD...more doubt on the safety of the drug Trasylol (apr...oing surgery. , Trasylol is already the subject... removed from the market in 2007. , In the new ...d findings from 49 randomized clinical trials. The...
(Date:12/2/2008)...r sexual assault are unsettling; the Department of...ll be the victim of attempted or actual sexual ass...esearchers from two universities, including the Un...n often are unaware of drug-facilitated sexual ass...aviors, including leaving drinks unattended. , ...
(Date:12/2/2008)...Newswire/ -- Seniors, disabled,Michiganders, stat...ay to,oppose efforts by Blue Cross to jam anti-co...e duck session of the Legislature. , "This ...in Michigan," said,RoAnne Chaney, Health Policy M...on. "A vote for this bill is a vote to dramaticall...
(Date:12/2/2008)... of enterprise software and online services vetera...subscribers of Yugma,s instant web conferencing so... (PRWEB) December 2, 2008 -- Yugma , the leading ...and collaborate instantly using the Internet, anno...xecutive Officer. , , ,Vas has more than 20 years ...
Breaking Medicine News(10 mins):Health News:Another Study Warns of Risk From Cardiac Surgery Drug 2Health News:MU researcher calls for increase in sexual assault awareness programs on college campuses 2Health News:MU researcher calls for increase in sexual assault awareness programs on college campuses 3Health News:Opposition Continues to Grow to Blues' Legislation 2Health News:Opposition Continues to Grow to Blues' Legislation 3Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 2Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 3
...ed by people with antibiotic-resistant bacterial i... of acquiring// these dangerous infections, accord...llin-resistant Staphylococcus aureus (MRSA) and va... kinds of antibiotic resistant bacteria which are ...
...erned by her ovaries according to a new report.The...consin-Eau Claire// showed that women put more tim...ulating. Not only does a woman’s clothes and make...a woman’s strength, appetite and attitudes toward...
...hree women and three kids, were killed and 27 were...ten fish at a government-run relief camp in Chhatt...day. Medical teams were sent late Monday to the re...e in the Maoist insurgency-hit district, 560 km so...
... 85 percent of colon cancer (carcinoma) cases has .../of Utah's Huntsman Cancer Institute, which could ... cancers in the future. Researchers were able to... a mutation in the adenomatous polyposis coli (APC...
Other Medicine News:Health News:Women’s Fashion Sense Linked to Her Ovulatio 2Health News:Novel Techniques to Tackle Colon Cancer 2
(Date:12/1/2008)...1 GeoVax Labs, Inc.,(OT...ology company developing,human vaccines for disea... and,other infectious agents, announced today tha... will take place in twelve sites across North and ...aboration with The National Institutes of,Health ...
(Date:11/30/2008)...1 Abnormalities in audi...hildren with autism spectrum disorder by using mag...esented today at the annual meeting of the Radiolo..."Using MEG, we can record the tiny magnetic fields...Timothy Roberts, Ph.D., vice chair of research in ...
(Date:11/27/2008)...s the majority of acute lymphoblastic leukemia rel...e time of diagnosis , , MEMPHIS, Tenn., Nov...Jude Children,s Research Hospital have identified ... children with acute lymphoblastic leukemia (ALL) ...o designing treatments for ALL relapse in children...
(Date:11/26/2008)... to 406 Subjects , , FRANKLIN, Mass., Nov. ... Bulletin Board: PLCSF) announced today that it ha...ug Administration (FDA) for its U.S. pivotal trial...Guard System(TM) and associated therapy in the pr... , The FDA also approved PLC,s request to ex...
Breaking Medicine Technology:GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4NAIRO Supports Uniform Health Carrier External Review Model Act Adopted by NAIC 21409 1NAIRO Supports Uniform Health Carrier External Review Model Act Adopted by NAIC 21409 2Touch Bionics wins the 2008 MacRobert Award i LIMB Hand recognised as the leading engineering innovation of the year 5896 1Touch Bionics wins the 2008 MacRobert Award i LIMB Hand recognised as the leading engineering innovation of the year 5896 2Decreased total sleep time associated with increased REM sleep during subsequent naps 21405 1Decreased total sleep time associated with increased REM sleep during subsequent naps 21405 2Treatment at an AASM accredited sleep center improves long term CPAP compliance 21401 1Treatment at an AASM accredited sleep center improves long term CPAP compliance 21401 2Treatment at an AASM accredited sleep center improves long term CPAP compliance 21401 3
...E)--Jun 21, 2007 - BioSante,Pharmaceuticals, Inc. ...ealth Initiative (WHI) Coronary Artery Calcium Stu...of Medicine (NEJM).,The study found that younger m...rd dose of estrogen therapy had significantly less...tudy period,compared with those taking placebo. Co...
...IRE)--Jun 21, 2007 - Opexa,Therapeutics, Inc. (NAS...nd commercialization of cell therapies, today,anno...e I/II,extension clinical trial of the investigati...erosis (MS). In this one-year,8-subject extension...secondary progressive (SPMS) subjects, Tovaxin the...
Other Medicine Technology:New Analysis of WHI Data Shows Reduced Levels of Coronary Artery,Calcification, a Predictor of Cardiovascular Events, in Women aged,50-59 taking Estrogen Therapy 2New Analysis of WHI Data Shows Reduced Levels of Coronary Artery,Calcification, a Predictor of Cardiovascular Events, in Women aged,50-59 taking Estrogen Therapy 3New Analysis of WHI Data Shows Reduced Levels of Coronary Artery,Calcification, a Predictor of Cardiovascular Events, in Women aged,50-59 taking Estrogen Therapy 4Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 2Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 3Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 4Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 5